Business Description
Turn Therapeutics Inc
NAICS : 541714
SIC : 8731
ISIN : US90021W1053
Total Employee Number:
2Description
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.87 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 0.98 | |||||
Debt-to-EBITDA | -0.9 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67.01 | |||||
9-Day RSI | 66.94 | |||||
14-Day RSI | 66.47 | |||||
3-1 Month Momentum % | 91.64 | |||||
6-1 Month Momentum % | 36.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.23 | |||||
Quick Ratio | 2.23 | |||||
Cash Ratio | 2.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -3.45 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -117.28 | |||||
ROA % | -38.91 | |||||
ROIC % | -121.78 | |||||
ROC (Joel Greenblatt) % | -8001.19 | |||||
ROCE % | -107.83 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 36.62 | |||||
Price-to-Tangible-Book | 45.24 | |||||
EV-to-EBIT | -33.31 | |||||
EV-to-EBITDA | -33.59 | |||||
EV-to-FCF | -57.25 | |||||
Earnings Yield (Greenblatt) % | -3 | |||||
FCF Yield % | -1.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TTRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Turn Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.128 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 66.47 | ||
| 14-Day ATR ($) | 0.578994 | ||
| 20-Day SMA ($) | 6.15525 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 2.5701 - 26.5 | ||
| Shares Outstanding (Mil) | 29.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Turn Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Turn Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-30 | In 147 days | ||
| Second quarter earnings results for 2026 | 2026-08-31 | In 56 days | ||
| General meeting for 2026 | 2026-07-09 | In 3 days | ||
| JefferiesJefferies Global Healthcare Conference | 2026-06-04 09:55 | 6.02 (-4.44%) | ||
| First quarter earnings results for 2026 | 2026-05-11 | 3.79 (+3.55%) | ||
| Annual report for 2025 | 2026-03-31 | 3.22 (-3.30%) |
Show
Entries
Turn Therapeutics Inc Frequently Asked Questions
What is Turn Therapeutics Inc(TTRX)'s stock price today?
The current price of TTRX is $7.69. The 52 week high of TTRX is $26.50 and 52 week low is $2.57.
When is next earnings date of Turn Therapeutics Inc(TTRX)?
The next earnings date of Turn Therapeutics Inc(TTRX) is 2026-08-31 Est..
Does Turn Therapeutics Inc(TTRX) pay dividends? If so, how much?
Turn Therapeutics Inc(TTRX) does not pay dividend.
Guru Commentaries on NAS:TTRX
No articles.
Press Release
Articles on Turn Therapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers